SEC Form 4 · accession 0001179110-17-013753
Care.com Inc · CRCM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Krupinski
Officer — Chief Technology Officer
Period of report
Nov 1, 2017
Accepted (ET)
Nov 3, 2017 · 6:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001412270
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 par value | Nov 1, 2017 | M | 5,000 | $3.70 | A | 180,678 | D | |
| Common Stock, $0.001 par value | Nov 1, 2017 | M | 5,000 | $6.02 | A | 185,678 | D | |
| Common Stock, $0.001 par valueF2 | Nov 1, 2017 | S | 10,000 | $14.9219 | D | 175,678 | D | |
| Common Stock, $0.001 par value | Nov 2, 2017 | M | 10,000 | $2.68 | A | 185,678 | D | |
| Common Stock. $0.001 par valueF5 | Nov 2, 2017 | S | 10,000 | $17.0016 | D | 175,678 | D | |
| Common Stock, $0.001 par value | Nov 3, 2017 | M | 20,000 | $2.68 | A | 195,678 | D | |
| Common Stock, $0.001 par valueF7 | Nov 3, 2017 | S | 10,000 | $18.0063 | D | 185,678 | D | |
| Common Stock, $0.001 par valueF8 | Nov 3, 2017 | S | 10,000 | $19.0068 | D | 175,678 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3 | $3.70 | Nov 1, 2017 | M | 5,000 | D | — | Feb 21, 2022 | Common Stock, $0.001 par value | 5,000 | 15,000 | D |
| Stock Option (Right to Buy)F4 | $6.02 | Nov 1, 2017 | M | 5,000 | D | — | Feb 28, 2023 | Common Stock, $0.001 par value | 5,000 | 42,000 | D |
| Stock Option (Right to Buy)F6 | $2.68 | Nov 2, 2017 | M | 10,000 | D | — | Dec 8, 2020 | Common Stock, $0.001 par value | 10,000 | 70,000 | D |
| Stock Option (Right to Buy)F6 | $2.68 | Nov 3, 2017 | M | 20,000 | D | — | Dec 8, 2020 | Common Stock, $0.001 par value | 20,000 | 50,000 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 8, 2017.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.92 to $15.38, inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.
- F3The underlying shares subject to the option vest and became exercisable in successive, equal quarterly installments over four years measured from February 1, 2012.
- F4The underlying shares subject to the option vest and became exercisable in successive, equal quarterly installments over four years measured from February 1, 2013.
- F5The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.00 to $17.05, inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (5) to this Form 4.
- F6The underlying shares subject to the option vest and became exercisable in successive, equal quarterly installments over four years measured from November 16, 2010.
- F7The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.10, inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (7) to this Form 4.
- F8The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.00 to $19.03, inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (8) to this Form 4.